CANCER BUZZ cover art

All Episodes

CANCER BUZZ — 319 episodes

#
Title
1

Real-World Oncology Decentralized Trials

2

The Real Cost of Cancer: Financial Toxicity, Transportation Challenges, and Access Gaps

3

Closing the Gap in Medical Necessity Review With a Clinical Documentation Integrity Registered Nurse

4

Utilizing APPs to Deliver Bispecific Antibodies in the Outpatient Setting

5

Between the Orders and the Infusion: The Patient Experience of Bispecific Antibodies

6

Centering Compassion in Cancer Care

7

A Pharmacist-Led Care Model for Oncolytic Virus Treatment Delivery

8

The Urology-Oncology Partnership in ADCs

9

A Team Approach to ADCs in Bladder Cancer

10

MDS: Low Risk Isn't No Risk

11

Beyond Body Art: Restoring Wholeness Through Paramedical Tattooing

12

Bridging Radiation and Oncology in SCLC Care

13

Championing Bispecific Antibodies in the VA

14

Data-Driven Toxicity Management for ADCs

15

Advancing Cancer Care Worldwide: ACCC Global eXchange

16

Designing Care That Creates Value for Patients and the Health System

17

A Collaborative Approach to Health Policy Changes

18

Closing the Gap Between Innovation and Implementation: Strategic Partnerships in Oncology

19

Becoming a Smart Consumer of AI as an Oncology Leader

20

BsAbs: Moving from Curiosity to Confidence

21

Innovation in Action: Breaking Down the 2025 ACCC Impact Report

22

Transforming Palliative Care in Oncology

23

Streamlining Access to TIL Cell Therapy for Melanoma

24

Policy in Practice: Change Hits the Clinic

25

Addressing Psychosocial Distress With Psychedelic-Inspired Therapies

26

Set Goals in Today's Health Care Reality

27

Plans for 2026: A Dialogue With ACCC's Executive Director

28

APPs Paving the Way in Leadership

29

Training the Next Generation of Oncology Leaders

30

Introducing Oncology Unscripted

31

CAR T-Cell Therapy Insights from the Field

32

Claudin 18.2 Reshaping Gastric Cancer Treatment

33

Navigating R/R FL: A Patient Centered Approach

34

1st Guest 6 Years Later

35

Championing Lung Cancer Clinical Trials in the VA

36

Exploring FGFR2b in Gastric and GEJ Cancer

37

Unlocking ESR1 Mutations in Breast Cancer

38

Retired Nurses Supporting the Workforce

39

LIVE from NOC: Women Leaders in Oncology

40

LIVE from NOC: Hot Topics

41

LIVE from NOC:Serving a Growing Patient Population

42

LIVE from NOC: Psychosocial Care, Alcohol, Marijuana and more

43

LIVE from NOC: Exec Dir on Unleashing Innovation

44

2025 Trending Now in Cancer Care: Part 2

45

2025 Trending Now in Cancer Care: Part 1

46

A Patient-Centered Approach to CDK4/6 Inhibitors

47

Bridging the AYA Survivorship Gap

48

Real World Models for APP Onboarding

49

Blood Cancer Awareness Month

50

Workplace Culture

51

A Patient and Her Care Team on Trust + Clinical Trials

52

Bridging the Gap: Enhancing Cancer Care Through Financial Navigation

53

Managing CDK4/6 Inhibitor Toxicities in Breast Cancer

54

Increasing Access and Representation in Clinical Trials

55

Stay Ahead of the Curve on CDK4/6 Inhibitor Toxicities

56

Transforming Cancer Detection and Treatment

57

Adopting Machine Learning-Enabled Decision Support to Improve Oncology End-of-Life Outcomes

58

Ambulatory Care Excellence (ACE): Charting a New Path in Ambulatory Care Model and Coordination

59

Optimizing Germline and Somatic Testing in Prostate Cancer

60

Better Bladder Cancer Care, Closer to Home

61

ASCO E-Poster: Immune-Related Adverse Events

62

Implementing a Structured, Scalable Geriatric Oncology Program

63

Shaw at Home: An Oncology Specific Home and Community-Based Palliative Care Program

64

The Coordinator's Perspective – Driving Research Growth From the Ground Up

65

Improving Care Between Clinic Visits: A Sustainable Model for Remote Patient Monitoring

66

5 Ways to Improve Oncology Clinical Trials

67

Navigating Disparities and Challenges in BTC Care

68

Housing at Risk Program (H@RP)

69

Targeting Progress: Patient Perspective on Antibody-Drug Conjugates in Gynecologic Cancer Care

70

Understanding and Meeting the Unique Needs of Adolescents and Young Adults with Cancer

71

Navigating Disparities and Challenges in HCC Care

72

Bridging the Gap: Women's Health and Cancer Screening in Indigenous Communities

73

Shared Decision-Making in CLL

74

Pipeline Partners

75

Screening for Social Determinants of Health (SDOH)

76

Supporting Skin Health in Patients with Breast Cancer

77

LIVE from AMCCBS: AI in Oncology

78

LIVE from AMCCBS: Topline Takeaways

79

LIVE from AMCCBS: President Una Hopkins

80

LIVE from AMCCBS: Future of care ACCC/ASCO

81

LIVE from AMCCBS: President Nadine J. Barrett

82

LIVE from AMCCBS: Leading Policy Change at the State Level

83

LIVE from AMCCBS: Clinical Research Award Winner

84

Key Takeaways from a National Quality Improvement Initiative to Address Disparities in Bladder Cancer Care

85

ACCC Capitol Hill Day

86

Implementing Bispecific Antibodies: The Blueprint for Community Oncology Excellence

87

Missing Voices: Increasing Black Women's Engagement in Patient Reported Outcomes in Breast Cancer Treatment

88

Consumerism, Cultures of Happiness, and AI in Cancer Care

89

Best of ORM

90

Supportive Oncodermatology: Managing Skin, Hair, and Nail Toxicities in Cancer Care

91

Part 7 of a 7 Part Series: Advocating for Patients in Rural Communities

92

Starting Strong: The Role of Fellows in Medical Advocacy

93

Part 6 of a 7 Part Series: Barriers to Accessing Cancer Care in Nigeria

94

Empowering Community Cancer Providers: Resources for Sarcoma Care

95

Part 5 of a 7 Part Series: Lessons Learned in Sweden in Cancer Prevention and Early Detection

96

Part 4 of a 7 Part Series: Working to Improve Survival Rates and Patient Education in Egypt

97

Exploring Bispecific Antibodies in Community Oncology: Overcoming Challenges and Harnessing Opportunities

98

Part 3 of a 7 Part Series: Examining the Public Health Landscape in Brazil

99

Impact of Medicare Part D Changes on Access to Care for Patients with Cancer

100

Part 2 of a 7 Part Series: Advancing Early Detection, Prevention, and Clinical Trial Diversity in Puerto Rico

101

Part 1 of a 7 Part Series: Challenges Faced by Patients with Cancer Across the Globe

102

Empowering Patients with Cancer to Self-Schedule New Patient Consultations

103

Live from NOC: The Hawaiʻi Cancer Consortium

104

Live from NOC: Navigating Access and Equity

105

Live from the NOC Gala

106

Live from NOC: Enhancing Cancer Research Through Patient Advocacy

107

Live from NOC: Realizing Innovation + What's New in 2024

108

Live from NOC: Come Together: A Global Perspective on Cancer Care Delivery

109

Live from NOC: Culturally Tailored Survivorship Care

110

2024 Trending Now in Cancer Care

111

Establishing Goals of Treatment in Relapsed/Refractory Mantle Cell Lymphoma

112

Developing a Health Equity Playbook

113

Shared Decision Making in Relapsed/Refractory Mantle Cell Lymphoma

114

Psychosocial Support in Head and Neck Cancer Care

115

Addressing Sexual Health in Oncology Patients

116

Care Coordination for Advanced Non-Melanoma Skin Cancers

117

A Practice Within a Practice: Integrating Oncodermatology into Comprehensive Cancer Care

118

Adverse Event Management in Relapsed/Refractory Mantle Cell Lymphoma

119

How Do I Say It? Patient-Provider Communication in Diffuse Large B-Cell Lymphoma Care

120

Addressing Frequency of Care to Improve Quality of Life in Patients with Low-Risk Anemia

121

Creating a Community-Wide Safety Net for Centralized Tracking and Management of Incidental Lung Nodule Findings

122

Empowering Laboratory Professionals to Optimize Biomarker Testing

123

A One-Stop Breast Clinic Improves Time to Diagnosis and Patient Satisfaction

124

Defining and Managing Erythropoietin Stimulating Agents (ESAs) Failure in Patients with Low-Risk MDS

125

A Sustainable Model for Improved Quality for Pancreatic Cyst Surveillance and Early Pancreatic Cancer Detection

126

Smart-Texting High-Risk Patients After Chemotherapy Reduces ED Visits

127

Promoting Equitable Care through the 4R Oncology® Model

128

Implementation of a Bispecific T-Cell Engager Therapy Program at a Community Cancer Center

129

Leveraging the EHR to Automate Biosimilar Selection and Streamline the Prior Authorization Process

130

Community CAR T-Cell Patient Identification Framework

131

Social Determinants of Health in Metastatic Breast Cancer

132

Overcoming Barriers to Holistic Survivorship Care for Immunotherapy Patients

133

Integrating Genetic Counselors in Routine Genitourinary Care

134

A Multidisciplinary Approach to Anemia Management in High-Risk MDS and AML

135

Improving Care Delivery to Patients Newly Diagnosed with Breast Cancer

136

Highlights from the ACCC Working Summit: Advancing CAR T-Cell Therapy Care Continuity and Collaborative Patient Education

137

Care Action Plans for People with Cancer

138

Beyond the Brush: Navigating Dental Care in Head & Neck Cancer

139

Navigating the Operational Challenges of Treatment with Bispecific Antibodies

140

Policy Perspectives on Biomarker Testing Coverage for 2024

141

Open Enrollment: Best Practices for End-of-Year Prep

142

Disparities in Accessing Care for AML Patients: Challenges and Solutions

143

Clarifying the Role of Maintenance Therapy

144

A Conversation With ACCC's Outgoing and Incoming Presidents at the ACCC 50th Annual Meeting and Cancer Center Business Summit

145

LIVE from AMCCBS: White House Update

146

LIVE from AMCCBS: Capitol Hill Update

147

LIVE from AMCCBS: Institute for Comprehensive Cancer Care Services

148

LIVE from AMCCBS: New Payments for Patient Navigation

149

LIVE from AMCCBS: Financial Advocacy Resources

150

Making the Case for Head & Neck Cancer Patient Care Navigators

151

The Florez Lab: Increasing Retention and Improving Productivity of Under-Represented in Medicine Trainees

152

BRCA Testing Survey Insights: A Multidisciplinary Perspective on Testing and Treatment for Patients with Breast Cancer

153

Championing an Institutional Culture of Well-being in a Post-Pandemic Oncology Workforce

154

Missed Care Conversations for Patients with DLBCL

155

Community CAR T-Cell Patient Identification Framework

156

The Future of the Patient Experience

157

Highlights from the ACCC Working Summit: Biomarker Testing – Solutions for EHR Integration

158

Developing a Disease-Site Specific Oncology Patient Navigation Program

159

Germline and Somatic Testing for Ovarian Cancer

160

AML Care Coordination in the Community Setting

161

Live from NOC: AI in Precision Oncology

162

Live from NOC: Technology Support for Health Care Workforce

163

Live from NOC: ACCC Priorities for the President's Cancer Panel

164

Live from NOC: Recruiting Strategies

165

Live from NOC: Leadership for Challenging Times

166

Live from NOC: Rural Appalachian Lung Screening Initiative

167

NOC Preview: Biomarker Testing for Medicaid Beneficiaries

168

NOC Preview: Financial Advocacy Guidelines to Mitigate Financial Toxicity

169

Examining Shared Decision-Making in Bladder Cancer Care

170

Importance of Clinical Team to Recognize SCLC

171

Leveraging Technology to Develop an Express Symptom Management Program & Prevent Oncology ED Visits

172

Strategies to Address Regional Barriers to Care in CLL

173

Combatting Caregiver Isolation Through Awareness and Education

174

The Role of the Clinical Trials Navigator

175

Collaborative Care: A Model for Embedding Counseling in Oncology and Palliative Care

176

Practical Tips for Providers to Empower Caregivers

177

Standardizing Comprehensive Biomarker Testing in Non-Small Cell Lung Cancer

178

There is No One-Size-Fits-All Care Plan for Caregivers

179

e-Consults for Immune-Related Toxicities Improve Patient Access and Reduce Costs

180

The Role of Nursing in Post-Pandemic Care of SCLC

181

A Model for Demonstrating Sustainable Outreach for Cancer Screening

182

Caregiving: Examining Psychosocial Care for Those Who Experience Distress Due to Their Caregiving Role

183

Developing an Advanced Practice Radiation Therapist Role

184

Leveraging Technology to Streamline Biomarker Testing

185

Building Support for Patients with NTRK Gene Fusion-Positive Cancer

186

Critical Conversation Strategies for Patients with AML

187

Treating Small Cell Lung Cancer Through Multidisciplinary Enhanced Supportive Care

188

Medical Hypnosis: A Complimentary Therapy for Patients in Active Treatment

189

Strategies to Addressing Disparities in Patients with AML

190

A New Registry Study for a Rare Form of Breast Cancer

191

Biomarker Testing for NTRK Gene Fusions

192

Cancer Care Team Mental Health: Normalizing Helpers Seeking Help

193

Key Highlights from an ACCC Survey on Remote Patient Monitoring

194

Alleviating the Psycho-social Burden of MPNs

195

Myelofibrosis: Advances in Treatment and Therapy

196

ACCC's 2023 Advocacy Agenda and Priorities

197

Symptoms Scoring and Risk Stratification for Myelofibrosis

198

Utilizing Subcutaneous and IV Treatment for Improved Outcomes with Multiple Myeloma Patients

199

A Better Patient Experience in the Management of Incidental Lung Nodules

200

In the Know: New Treatment Guidelines for Myeloproliferative Neoplasms

201

Mitigating the Financial Burden of Cancer Diagnostics

202

Getting the Green Light for Precision Medicine Stewards

203

The Impact of Integrated Care on Myeloproliferative Neoplasms (MPNs)

204

Treatment Options for Patients with Multiple Myeloma Who Are Ineligible for Transplant

205

Best Practices in Caring for Patients with CLL in a Post-COVID Era

206

Addressing Regional Challenges to Equitable Care for Patients with CLL

207

Robots, Biologics, and Advocates: Lessons from the Pharmacy

208

Precision Medicine: Stories from the CRISPR Revolution

209

The Urgency of MPN Treatment – Why Timing Matters

210

The Role of Population Health Navigators

211

Prioritizing a Multidisciplinary Team Approach in the Care of Patients with Small Cell Lung Cancer

212

Nurses' Role in Oral Oncolytics for CLL

213

A Conversation with ACCC Board Member Dr. Nadine Barrett

214

Improving Clinical Efficiency: EHR & MPN10 Integration

215

Multi-Cancer Early Detection: Legislative Landscape

216

Optimizing SCLC Patient Outcomes Through Multidisciplinary Care Coordination

217

Advanced Skin Cancer Care for Rural Populations

218

The Importance of Having Difficult Conversations with Patients

219

Engaging Patients with Small Cell Lung Cancer in Clinical Trials

220

Social Media as a Platform to Deliver Patient Education

221

Navigating Cancer Diagnostics – A Closer Look at the Role of the Precision Medicine Steward

222

Technology That is Transforming Cancer Care

223

Is It time to Cancel the Term "A Cure for Cancer"

224

Overcoming Health Disparities through Remote Patient Monitoring

225

Financial Barriers to Oral Cancer Therapies

226

LIVE from NOC: Leveraging Data to Tackle Workforce Shortages

227

LIVE from NOC: Building Sustainable Coalitions in Your Community

228

LIVE from NOC: A Support Program to Improve Staff Well-Being

229

LIVE from NOC: Advocates Weigh-In on Financial Advocacy Guidelines Update

230

LIVE from NOC: Financial Advocacy Guidelines

231

Successful Integration of Oral Oncolytics

232

Patient Adherence to Oral Targeted Therapies

233

CAR T-cell Therapy: Remote Patient Monitoring

234

Addressing Challenges in Managing Patients Receiving Oral Therapies for HR+, HER2- Breast Cancer

235

Interventional Screening Tools for Malnutrition

236

Sexual Health: All of Me

237

Malnutrition: Screen or Assess?

238

Anti-Cancer Therapy Privileging for APPs

239

Expediting Cancer Treatment Through a Rapid Access APP-Led Diagnostic Clinic

240

Deploying Technology Across an Interdisciplinary Team to Improve Oral Oncolytic Compliance

241

Chemotherapy Care Companion: A Remote Patient Monitoring Program

242

Malnutrition in Cancer Care

243

A Model for Embedding Primary Care in Oncology

244

Oral Cancer Therapy: Adverse Events

245

Addressing Social Determinants of Health through a Medical-Legal Partnership

246

Digital Literacy in Older Adults with Cancer

247

Cannabis and Cancer: Developing a Patient Clinic

248

Advocating for Financial Health

249

Pharmacy Benefit Managers: How Advocacy Led to Action

250

Increasing Clinical Trial Access for Blood Cancers

251

Expanding the Role of Advanced Practitioners to Address the Care Gap

252

Liquid Biopsy: Cancer Detection & Future Synergies

253

Two ACCC Presidential Themes Converge at One Annual Meeting

254

The Promise of MRD Testing in Multiple Myeloma & CLL

255

State Advocacy Matters

256

Jack's Caregiver Coalition

257

Virtual Integrative Services

258

AMCCBS LIVE: Precision Medicine Reimbursement

259

AMCCBS LIVE: Care Measurement

260

AMCCBS LIVE: Cancer Moonshot

261

AMCCBS LIVE: Industry Reconfiguration Trends

262

Digital Patient Assistance Guide

263

Improving Pathology Reports

264

Developments in TIL Cell Therapy

265

The Business Case for Hiring Oncology Social Workers

266

Biomarker Testing Advocacy

267

Genetic Counseling Advocacy

268

Leading with Gratitude

269

QI in Advanced NSCLC

270

A New Deal for Cancer

271

Precision Medicine Disparities

272

Shared Decision-Making in Acute Myeloid Leukemia

273

Genetic Testing & Telehealth

274

Cancer Care's Road to Recovery from the Global Pandemic

275

Supportive Care in Radiation Oncology

276

Financial Advocacy Playbook

277

Coping with Pandemic Grief

278

CLL, COVID-19, & Why Patient Registries Matter

279

Integrating Advanced Practitioners into Research

280

Implementing a Transportation Hub

281

Chronic Lymphocytic Leukemia: Navigating Uncertainty

282

A Summer of Disconnect for Cancer Professionals

283

Advanced Practitioners' Role in Research

284

Oncology Billing & Coding Fundamentals

285

CLL Patient Education in Transitional Times

286

The IT Professional as a Multidisciplinary Team Member

287

Advancing Clinical Trial Equity

288

Myeloma Care Strategies & COVID-19

289

Real-World Lessons from COVID-19

290

Collaboration and Innovation in the Time of COVID-19

291

Impact of COVID-19 on Revenue Optimization

292

COVID-19 Challenges: Managing Patients with CLL

293

What Comes Next for Telehealth?

294

What You Need to Know about Liquid Biopsy

295

The Spiritual Side of Cancer Care

296

Telehealth & Genetics During COVID-19

297

End-of-Life Health Disparities

298

Cultural Humility & Sensitivity

299

Tracking Patient Adherence to Oral Anti-Cancer Medications

300

Building Trust with Marginalized Groups

301

LGBTQ+ Patients with Cancer

302

Telehealth After COVID-19

303

Supporting Caregivers During COVID-19

304

Psychosocial Oncology Services During COVID-19

305

The Promise of Bispecific Antibodies

306

Lung Cancer Screening During COVID-19

307

Managing Oral Anti-Cancer Medications

308

Lung Cancer Awareness Month

309

Shared Decision-Making

310

Biosimilars: What Patients Need to Know

311

Improving Community Clinical Trial Participation

312

Financial Barriers to Biomarker Testing

313

Closing the Gender Gap in Oncology

314

Immunotherapy & Dermatology

315

Lessons Learned from COVID-19

316

Understanding COVID-19 Data

317

Surgical Oncology During COVID-19

318

Reducing Cancer Drug Waste

319

Cancer Screening During COVID-19